$1.45
-0.18-11.04%
At close: Jun 5, 5:00 PM EST
$1.43
-0.0172-1.19%
After Hours: 7:24 PM EST
Pacific Biosciences of California Inc Stock Guidance
PACBNASDAQ
Pacific Biosciences (PACB) last issued guidance on May 7, 2026 for fiscal year 2026. The company guided revenue in the range of $165.00M - $175.00M for the period.
Compared to prior guidance, Pacific Biosciences raised its revenue forecast from a prior range of $44.60M - $44.60M.
Pacific Biosciences has issued 14 guidance updates between August 3, 2022 and May 7, 2026. During this period, the company raised its outlook 4 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 7, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$165.00M - $175.00M
Pacific Biosciences Guidance History
Review all historical guidance issued by Pacific Biosciences, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Pacific Biosciences (PACB)?
The most recent guidance for Pacific Biosciences (PACB) was reported on May 7, 2026 for the fiscal year 2026. Pacific Biosciences forecasted revenue between $165.00M and $175.00M for the period.
What revenue range did Pacific Biosciences (PACB) guide for?
Pacific Biosciences (PACB) guided revenue in the range of $165.00M to $175.00M for the fiscal year 2026.
Did Pacific Biosciences (PACB) raise or lower guidance?
Pacific Biosciences (PACB) raised its revenue guidance from a prior range of $44.60M - $44.60M to $165.00M - $175.00M for the fiscal year 2026.
When did Pacific Biosciences (PACB) last issue guidance?
Pacific Biosciences (PACB) last issued guidance on May 7, 2026 for the fiscal year 2026.
